tirzepatide and lithium FDA confirms shortage is still over, gives compounders a grace period Eli Lilly's diabetes drug tirzepatide

& Ibrahim, A

The Right Fit Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions Patients who have plateaued on a single-agonist GLP-1 and want to escalate under supervision Members for whom faster onset and higher trial averages are clinically appropriate Not Appropriate For Personal or family history of medullary thyroid carcinoma or MEN 2 Pregnancy, breastfeeding, or planning pregnancy Active pancreatitis or untreated severe gastrointestinal disease What to Expect What to Expect Tirzepatide tends to act faster and reach further than single-agonist GLP-1s

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort

How Beta-Alanine Works The Top 4 Benefits of Beta-Alanine